Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks (Q35496697)

8 August 2017

Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks (English)

1 reference

8 August 2017

1 reference

1 reference

Dean T Eurich

1

1 reference

8 August 2017

Sumit R Majumdar

2

1 reference

8 August 2017

Finlay A McAlister

3

1 reference

8 August 2017

Ross T Tsuyuki

4

1 reference

8 August 2017

Jeffrey A Johnson

5

1 reference

8 August 2017

22 February 2011

1 reference

8 August 2017

1 reference

8 August 2017

5

1 reference

8 August 2017

1

1 reference

8 August 2017

e33-4

1 reference

Metformin use and mortality among patients with diabetes and atherothrombosis

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205816

Metformin use and mortality in ambulatory patients with diabetes and heart failure

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205816

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205816

Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205816

Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205816

Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205816

Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205816

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205816

Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205816

Improved clinical outcomes associated with metformin in patients with diabetes and heart failure

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205816

Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205816

26 September 2018

Identifiers

PMCID

3205816

1 reference

8 August 2017

1 reference